Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 57.3B 19M Jun/2026
Biogen USD 7.69B 398.3M Sep/2026
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 254.94B 68.86B Sep/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
Geron USD 122.14M 78K Jun/2026
J&J USD 49.04B 5.95B Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Novartis USD 49.01B 2.02B Jun/2026
Novavax USD 233.31M 4.23M Sep/2024
Pfizer USD 62.67B 523M Sep/2026
Roche Holding CHF 33.03B 1.41B Jun/2025